eCOA LingCert Accreditation Program

Certify your eCOA platform to ensure it meets industry standards and best practices to host multilingual content.

Check Accredited Platforms
Patient holding a tablet with an electronic clinical outcome assessment

What is the eCOA LingCert program?

As the world's largest provider of language and technology solutions with an extensive knowledge base of subject matter experts, TransPerfect Life Sciences is uniquely positioned to offer customizable roadmaps and provide accreditations to vendors.

The eCOA LingCert program assesses an eCOA platform’s capabilities against industry standards and best practices within the following four key pillars:

  • Icon Document 2

Content Management

  • Icon Global

Internationalization

  • Icon Progress Improvement

Content Reusability

  • Icon Compliance Check Mark

Post-localization Testing

eCOA Platform Accreditation Levels

  • Icon eCOA LingCert Silver
  • Silver

    Beginner silver-level standards around functional and fundamental capabilities in global clinical trial support.

  • Icon eCOA LingCert Gold
  • Gold

    Integrated translation content portal, fully automated screenshot review, or in-context emulation.

  • Icon eCOA LingCert Platinum
  • Platinum

    Meets previous compliance levels, alongside platinum-level content reuse and library hosting.

    Accredited eCOA Platforms

    Clario

    Platform: eCOA Tablet

    Accreditation Level: Silver 

    Clinical ink

    Platform: Direct Data Capture

    Accreditation Level: Silver 

    Benefits for eCOA Clients and Sponsors

    Improve data collection and integrity by enhancing quality via platform consistency across different studies.


    60+ %

    Faster Timelines

    60 +%

    Reduced Costs

    75 %

    Reduced Project Management Timelines

    Your Journey to eCOA Accreditation

    Achieve the highest level of accreditation with a customized road map based on your company's current standing between our Silver, Gold, and Platinum levels. The accreditation meeting process includes:

    1. Initial Consultation

    An initial consultation is set to determine the eCOA company's current compliance status in relation to Silver, Gold, and Platinum Standards.

    2. Certification Report Shared

    A detailed report is then shared which outlines the steps for achieving the next level of accreditation, customized to your company's unique needs.

    3. Follow-up Meetings

    Ongoing support and guidance as needed is established through regular correspondence and meeting cadence to address questions and progress towards accreditation.

    4. Certification Awarded

    Official recognition is awarded to your platform for complying with the required standards.

    5. Annual Check-in

    A yearly review is established to confirm that there are no significant changes made to affect the platform's accreditation status. TransPerfect will also provide insights on latest trends and innovation in the eCOA space for continuous improvements and innovation.

    eCOA Linguistic Certification

    By earning a certification through our eCOA LingCert program, your organization will: 

    • Create a customizable and efficient roadmap to improve eCOA platform standards

    • Optimize technological capabilities for hosting multilingual content and global studies 

    • Meet best practices while speeding up timelines and enhancing quality 

    • Increase marketability to sponsors 

    eCOA Thought Leadership

    LifeSci Talks COA Series | From Interview to Endpoint: Understanding the Importance of Patient Listening to Build Better Outcomes

    In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with John Reites, Co-Founder and CEO of THREAD research to discuss the importance of patient listening to build better clinical trial endpoints. They delve into the differences between enterprise and standalone solutions, challenges with standardization, and the influence of evolving technologies in the eCOA industry. ...

    LifeSci Talks COA Series | From Interview to Endpoint: Understanding the Importance of Patient Listening to Build Better Outcomes

    Selecting an eCOA Vendor to Best Fit Localization Needs

    One of the main challenges for pharma/biotech companies regarding clinical trials is prolonged eCOA study start-up. It is paramount to choose the right eCOA platform for each study. Sponsors must consider the study’s specific needs, such as user-friendliness, compliance,...

    AI and MT "Ask an Expert" Office Hours - 4/10/2024

    TransPerfect's experts gather to answer questions from global pharma, biotech, and medical device leaders regarding AI and MT use cases, challenges, opportunities, best practices, and more. ...

    LifeSci Talks COA Series | Exploring the Intersection of Clinical Practice and Entrepreneurship: Technological Innovation in Clinical Research

    In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Dr Michelle Longmire, CEO of Medable, to discuss her journey from clinical practice to entrepreneurship, driven by a passion for rare disease, and the ...

    Clinical Outcomes Assessments (COAs) in Clinical Trials: Copyright and Licensing

    Author: Maria Arnott and Corinne Shoch, COA/eCOA Licensing Management TeamIn clinical trials, it is usually necessary for sponsors to obtain permission to use copyrighted materials, such as clinical outcome assessments (COAs). The process to obtain these permissions is called...

    Localizing Platforms for Digital Health: The Importance of Post-Localization Context Review

    In a landscape defined by continuous technological advancement, many organizations in the life sciences industry strive to increase audience engagement through digital modalities, such as mobile and web applications or web portals.Building a robust technological...

    PRO Scheduling Considerations: Assessing Patient & Caregiver Burden in Clinical Trials

    In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Andrew Lloyd, Director at Acaster-Lloyd Consulting, to spotlight the burden of clinical research for patients, and their caregiver/family dynamics. From ...

    Want to see if you qualify for our accreditation program?

    Contact our team today to create your customized roadmap.

    How did you hear about us?
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.